Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Change in Receivables: 2021-2024

Historic Change in Receivables for biote (BTMD) over the last 4 years, with FY2024 value amounting to $2.3 million.

  • biote's Change in Receivables fell 15531.18% to -$479000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 2693.99%. This contributed to the annual value of $2.3 million for FY2024, which is 34891.09% up from last year.
  • As of FY2024, biote's Change in Receivables stood at $2.3 million, which was up 34891.09% from $505000.0 recorded in FY2023.
  • Over the past 5 years, biote's Change in Receivables peaked at $2.3 million during FY2024, and registered a low of $505000.0 during FY2023.
  • In the last 4 years, biote's Change in Receivables had a median value of $1.2 million in 2021 and averaged $1.3 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first tumbled by 6766.97% in 2023, then surged by 34891.09% in 2024.
  • biote's Change in Receivables (Annual) stood at $752000.0 in 2021, then soared by 107.71% to $1.6 million in 2022, then crashed by 67.67% to $505000.0 in 2023, then surged by 348.91% to $2.3 million in 2024.
  • Its last three reported values are $2.3 million in FY2024, $505000.0 for FY2023, and $1.6 million during FY2022.